Clinical Trials Logo

Breast Neoplasms clinical trials

View clinical trials related to Breast Neoplasms.

Filter by:

NCT ID: NCT02524548 Completed - Breast Cancer Clinical Trials

SMS Reminders to Improve Medication Adherence of Aromatase Inhibitors

Start date: May 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether weekly SMS reminders are effective in improving medication adherence of adjuvant aromatase inhibitors in women with breast cancer.

NCT ID: NCT02523417 Completed - Breast Cancer Clinical Trials

HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA)for Breast Cancer

Start date: May 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of HepaSphere interventional therapy using digital subtraction angiography(DSA)for breast cancer.

NCT ID: NCT02522260 Completed - Well Being Clinical Trials

OptiTrain - Optimal Training Women With Breast Cancer

OptiTrain
Start date: March 2013
Phase: N/A
Study type: Interventional

This study on women with breast cancer during and after chemo- and hormonal therapy compares the effect of different physical training programs on physical and mental well-being and systemic inflammation mechanisms in blood. In a sub-group of participants, mitochondrial biogenesis and function and other molecular processes in skeletal muscle biopsies are studied. The women will be randomly allocated into three different intervention arms, a control arm with usual care and two different training arms. All participants will respond to questionnaires and have blood samples and taken and for a subgroup muscle biopsies before and after the exercise intervention. Participants will be supported to uphold exercise through collaboration with Friskis & Svettis and followed for 5 years. Some of the women will also be asked to participate in an in depth interview about the experiences of exercise during ongoing treatment. This study will contribute to increased knowledge about the type, intensity and frequency of training that patients with breast cancer benefit most from with regards to impact on physical and mental wellbeing. This knowledge is of great importance since experience shows that patients and relatives often seek information about rehabilitation, self-care and physical activity. The study will also contribute to the improvement of the patients´ quality of life, ability to return to work, and reduce social costs, but above all, increase the possibility for development and implementation of evidence-based rehabilitation of women with breast cancer during and after active treatment.

NCT ID: NCT02521961 Completed - Breast Carcinoma Clinical Trials

Support Group Program in Improving Quality of Life in Underserved Urban Latina Breast Cancer Survivors

Start date: February 3, 2016
Phase: N/A
Study type: Interventional

This randomized clinical trial studies a support group program in improving quality of life in underserved urban Latina breast cancer survivors. A psychosocial support group program may help reduce distress and improve health-related quality of life in underserved urban Latina breast cancer survivors.

NCT ID: NCT02521623 Completed - Breast Neoplasms Clinical Trials

SurgiMend® vs. Strattice™ in Direct to Implant Breast Reconstruction- A Prospective Randomized Trial

Start date: August 2015
Phase: N/A
Study type: Interventional

An increasing number of women undergo an immediate breast reconstruction, where the mastectomy and the breast reconstruction are performed in the same surgery. To aid survival of the mastectomy skin flaps, and to provide better aesthetic results acellular dermal matrixes (ADMs) are used to reinforce the breast. There are several different types of ADM available for this purpose. In this randomized clinical trial, the following study will investigate two different types of ADM (Strattice™ and SurgiMend®) in an immediate breast reconstructive setting. Sixty patients will be allocated on a 1:1 ratio to receive either Strattice™ or SurgiMend® ADM. Patients scheduled for immediate breast reconstruction with ADM at pt. of Plastic and Reconstructive Surgery at Aarhus University Hospital, Aarhus, Denmark will be offered participation. In total, 60 patients will be included. Outcome parameters of interest are complication rate, patient satisfaction, aesthetic result and cost of the procedure. Satisfaction and aesthetic result will be measured at 4 and 12 months post surgery.

NCT ID: NCT02520063 Completed - Breast Cancer Clinical Trials

Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer

Start date: February 1, 2016
Phase: Phase 1/Phase 2
Study type: Interventional

This study will test how well a new combination of three drugs (Letrozole, Everolimus, and TRC105) is tolerated and how well it works in Stage 2 and 3 breast cancer when given prior to definitive surgery. Letrozole blocks the estrogen receptor expressed by many breast cancers while everolimus blocks signals that drive cancer cells to grow. TRC105 is an investigational drug that blocks the formation and growth of blood vessels that feed the cancer and promote its growth. The goal of this study is to investigate the safety and efficacy of this multitargeted approach in breast cancer.

NCT ID: NCT02518477 Completed - Breast Neoplasms Clinical Trials

Preventive Intervention Against Lymphedema After Breast Cancer Surgery

LYCA
Start date: September 2015
Phase: N/A
Study type: Interventional

This study will examine whether lymphedema after breast cancer surgery can be reduced. In a randomised controlled design the aim is to investigate whether an early intervention with progressive resistance training and close monitoring of arm swelling can reduce the incidence of lymphedema after breast cancer surgery.

NCT ID: NCT02518191 Completed - Breast Cancer Clinical Trials

Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity

Start date: September 1, 2015
Phase: Phase 3
Study type: Interventional

This prospective randomized controlled study is conducted to analyze the effect of Goserelin on ovarian function in women with breast cancer in China.

NCT ID: NCT02517593 Completed - Breast Cancer Clinical Trials

Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake

GENRE
Start date: March 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS), in addition to the standard National Cancer Institute's Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score, will aid women at risk of breast cancer in making a decision to take (or not take) medications to prevent breast cancer

NCT ID: NCT02515487 Completed - Breast Cancer Clinical Trials

An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer Survivors

Start date: September 2013
Phase: N/A
Study type: Interventional

The main goal of this project is to identify and remediate the cognitive difficulties, including processing speed and attention deficits in individuals who have undergone chemotherapy treatment. Recent research has demonstrated objective cognitive deficits following chemotherapy and that it is not an emotional reaction to the cancer diagnosis as it was once considered. There are a large number of woman diagnosed and treated for breast cancer that experience chemotherapy induced cognitive deficits. Subjects who participate in the study will be evaluated for cognitive abilities prior to chemotherapy treatment and after completion of chemotherapy. Participants will then have the option to participate in the second phase of the study, which involves the use of a computer-based Brain Fitness Program for 12 weeks. This is followed by another cognitive evaluation.